Empery Digital Announces Update on Share Repurchase Program
EMPD(NASDAQ:EMPD) AUSTIN, Texas--(BUSINESS WIRE)---- $EMPD #BTC--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today announced an update on its previously authorized share repurchase program. As of September 5, 2025, the Company has repurchased 1,626,007 shares of its common stock under its $100 million share repurchase program, at an average purchase price per share of $7.23, including all fees and commissions. This represents the maximum number of shares permitted to be repurchased in the open market
International Petroleum Corporation Announces Results of Normal Course Issuer Bid and Updated Share Capital
IPCO(IPCO) TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 289,393 IPC common shares (ISIN: CA46016U1084) during the period of August 25 to 29, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB).
BUTLER NATIONAL CORPORATION REPURCHASES 2.41 MILLION SHARES
BUKSCorporation Establishes New Stock Repurchase Program and Closes 2016 Program NEW CENTURY, Kan., Aug. 13, 2025 /PRNewswire/ -- Butler National Corporation (OTCQX: BUKS), a leader in the growing global market for aircraft modification, maintenance, repair and overhaul and a recognized...
WASTE CONNECTIONS RENEWS NORMAL COURSE ISSUER BID FOR SHARE REPURCHASES
WCNTORONTO, Aug. 8, 2025 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it has received approval from the Toronto Stock Exchange (the "TSX") for the annual renewal of its normal course issuer bid (the "NCIB"). The renewal...
BioRestorative Announces Share Repurchase Program
BRTXMELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026.